1. 华宝来,肖娟*,赵永强.使用药代动力学管理工具myPKFiT预测中国血友病A患者凝血因子Ⅷ活性.中国医学科学院学报.2023.45(2).200-205.核心期刊 |
2. 魏冲,蔡昊,华宝来,朱铁楠.一个表现为血栓的遗传性低异常纤维蛋白原血症家系.中华血液学杂志.2022.43(10).865-869.核心期刊 |
3. 熊春锦,华宝来,夏炳兰.超声引导下关节腔内注射重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白(益赛普)治疗血友病性关节病.中国介入影像与治疗学.2022.19(4).202-205.核心期刊 |
4. 华宝来*,李魁星,赵永强,郭杨.血友病B患者接受人凝血酶原复合物按需治疗后四种凝血因子体内回收率的观察.临床药物治疗学杂志.2022.20(11).17-21.核心期刊 |
5. 王冶凡,林振洋, 张飞旭, 周新月, 吴侠, 肖啸, 孙君江,华宝来.来那度胺对血友病性关节炎的治疗作用的研究.中国实验血液学杂志.2022.30(5).1549-1556.核心期刊 |
6. Baolai Hua*, Xiaobo Yan, Bin He, Lianjun Shen, Man-Chiu Poon.Protein S gene mutation c.946C > T (p.R316C) contributed to ischemic stroke in a man with von Willebrand disease type 3 caused by two novel VWF gene mutations, c.2328delT (p.A778Lfs* 23) and c.6521G > T (p.C2174F).Clinical Case Reports.2022.10(8).1-5.SCI |
7. Zhang F, Xu M, Yang Q, Hua B*, Xiao X, Monahan PE,Sun J..A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy..J. Clin. Med..2020.9(1).75.SCI |
8. He P, Zhang F, Zhong C, Li M, Zheng J, Hua B*, Sun J..Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice.Int J Hematol..2019.110(1).59-68.SCI |
9. 华宝来*,Chelle Pierre,Yeung Cindy HT.两种重组人凝血因子Ⅷ制剂在血友病A患者中的群体药代动力学研究.中华血液学杂志.2019.40(8).673-677.核心期刊 |
10. Zhong C, Szollosi D, Sun J , Hua B, Ghoneim O, Bill A, .Novel Piperazino Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model. .Inflammation..2019.42(5).1719-1729..SCI |